%20and%20Batch%20Production%20Records%20(BPR).png)
Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The regulator granted the application priority review for this indication, assig...
The value includes a $1.55bn upfront payment and as much as $1.1bn in regulatory...
Inspite of current geopolitical disruptions,both larger pharma enterprises and ...
As the era of hyper-globalisation appears to have run its course,with geopoliti...
Freight disruption,energy volatility,raw material dependencies and geopolitical...
Geopolitical fragmentation is accelerating the shift toward regional trials, lo...
One of the most persistent risks facing Indian pharma manufacturers is the indu...
From supply disruptions to rising operational uncertainty,geopolitics is reshap...
BCMA-directed bispecific antibody is available as a fixed-dose subcutaneous inj...
Technology transfer moves anti-GD2 monoclonal antibody programme from Californi...
Three-day event brings together nearly 3,000 stakeholders as Nutrify Today posi...
This marks the first approved immunotherapy combination for this patient segment...
The agreement covers Hanmi’s candidate that uses its LAPSCOVERY long-acting plat...
As geopolitical disruptions, increasing ESG pressures and shifting supply chain...
Former Sun Pharma, Cipla and Reliance Retail executive to lead sales and market...
India's Foremost Pharma & Biotech Magazine ~ Navigating A Vuca World The post E...
